Patient 1 | Patient 2 | Controls | ||
---|---|---|---|---|
Newborn screening | Unremarkable | Suggestive of MCADD | Unremarkable | |
Confirmatory testing | ||||
Acylcarnitines in dried blood spots (at different time points) | C6 | 0.06–0.27 μmol/l | 0.13–0.38 μmol/l | <1 μmol/l |
C8 | 0.11–1.56 μmol/l | 0.31–1.5 μmol/l | <0.4 μmol/l | |
C10 (including C4:1-DC) | 0.07–0.74 μmol/l | 0.16–0.93 μmol/l | <0.2 μmol/l | |
C10:1 | 0.07–0.63 μmol/l | 0.13–0.7 μmol/l | <0.2 μmol/l | |
[C8]/[C10] | 1.2–2.46 | 1.62–2.86 | <5 | |
[C8]/[C12] | 4.97–19.3 | 6.46–17.1 | <5 | |
[C8]/[C2] | 0.01–0.09 | 0.02–0.4 | <0.02 | |
Urinary organic acids (at different time points) | Hexanoylglycine | +/ n.d. | +/ n.d. | n.d. |
Isohexanoylglycine | +/ n.d. | +/ n.d. | n.d. | |
Suberylglycine | +/ n.d. | +/ n.d. | n.d. | |
Dicarboxylic acids | Not elevated | Not elevated | ||
Enzyme activity measurements in lymphocytes | Octanoyl-CoA-oxidation | 17 % (during fever) | 24 % (without fever) | 100 % |
13 % (during fever) |